Assist. Prof. Dr. Natalia Bilousova – Pharmaceutical care  –  Best Researcher Award 

Posted on by sciencefather

Assist. Prof. Dr. Natalia Bilousova - Pharmaceutical care  -  Best Researcher Award 

Shupyk National Healthcare University of Ukraine -  Ukraine 

Author Profile 

GOOGLE SCHOLAR 

🎓 Early academic pursuits

Natalia Bilousova embarked on her academic journey with a profound interest in clinical pharmacology. she earned her mph and subsequently a phd, laying a strong foundation in pharmaceutical sciences. her commitment to academic excellence led her to pursue a post-doctoral role at the cardiology department of the shupyk national healthcare university of ukraine in kyiv. early on, she demonstrated a deep inclination toward merging clinical practice with evidence-based research, which later shaped her career trajectory.

💼 Professional endeavors

With over 25 years of professional experience, natalia has worn many hats, including clinical pharmacist, academician, and researcher. she currently serves as an associate professor at the shupyk national healthcare university of ukraine. amidst wartime disruptions, she took part in an academic mobility program in 2022 at masaryk university, czech republic, showing her resilience and dedication to global health education. her participation in consultancy projects with pharmacy chains like “bazhaemo zdorovia” and “apteka nyzkykh tsin” showcases her practical engagement with the healthcare sector. her work in the domain of power electronics provides a novel lens for integrating digital systems in pharmaceutical education.

🔬 Contributions and research focus

Natalia’s research interests span across pharmacology, healthcare policy, pharmaceutical care in cardiovascular diseases, and mental health. her notable contributions include three clinical pharmacology guidelines for managing chronic coronary syndrome, elevated blood pressure, and ischemic heart disease in multidisciplinary teams. she’s also deeply involved in developing Pharmaceutical care continuing professional development (cpd) courses and pharmaceutical training modules. her innovative outlook ties in health technology assessment with real-time patient care — offering new dimensions of analysis, akin to the precision and integration found in power electronics applications.

🌍 Impact and influence

As a national and international speaker, natalia frequently addresses audiences via webcardio.org and scientific forums. her influence spans academia, industry, and public health Pharmaceutical care organizations. she plays an active role in shaping public policies through her board membership in public health and educational groups. her collaborations with pharmaceutical giants like teva, ratiopharm, arterium, and wörwag pharma reflect her trusted expertise in market research and medical promotion. her scholarly presence extends to the conceptual design of pharmaceutical care systems — a model as efficient and structured as a power electronics control scheme in high-demand environments.

📊 Academic cites

Natalia Bilousova’s academic contributions have garnered a citation index of 7 on google scholar and 1 on scopus. while modest, these numbers reflect her growing impact in niche research Pharmaceutical care areas such as health technology assessment and mental health-focused pharmaceutical care. her scholarly output includes six isbn-registered publications, some of which are monographs and methodological guides, including her 2024 work on pharmaceutical care for mental health patients.

📚 Legacy and future contributions

Natalia’s legacy is rooted in her dedication to refining pharmaceutical education and care practices. her recent books delve into topics like professional digital competence and medical technology assessment, emphasizing the evolving role of pharmacists in an increasingly tech-driven world. she is poised to continue her efforts in education transformation, particularly Pharmaceutical care through digitalization and interprofessional healthcare collaboration. future contributions are expected to address mental health services and integrative care models that could revolutionize pharmacy training — much like how power electronics has revolutionized modern energy systems.

Notable Publications 

  • Title: Conceptual model of pharmaceutical care for patients with coronary heart disease and comorbid conditions in Ukraine
    Author: N. Bilousova
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title: Research of affordability to essential medicines for coronary heart disease in Ukraine
    Authors: N. Bilousova, N. Tkachenko, N. Kozhuharyova, M. Dolzhenko
    Journal: Journal of Pharmaceutical Policy and Practice

  • Title : Adherence to treatment of patients with coronary heart disease and comorbid conditions: influence of socio-economic factors during martial law in Ukraine (first report)
    Authors: N.A. Bilousova, V.I. Nesukai, T.V. Simahina, M.M. Dolzhenko, O.P. Shmatenko, et al.
    Journal: Ukrainian Journal of Military Medicine

  • Title: An analysis of prescriptions for coronary heart disease with comorbid conditions in health care institutions of Ukraine
    Authors: N.A. Bilousova, M.M. Dolzhenko
    Journal: Current Issues in Pharmacy and Medicine: Science and Practice

  • Title: Preferences in the choice of original and generic drugs: pharmaceutical care for patients with coronary heart disease and comorbid conditions
    Authors: M.M. Dolzhenko, N.A. Bilousova, V.A. Nesukai, T.V. Simahina, et al.
    Journal: Modern Medical Technologies (Сучасні медичні технології)

Prof. Jerzy trojan – Immuno – gene therapy – Excellence in Innovation

Posted on by sciencefather

Prof. Jerzy trojan - Immuno - gene therapy - Excellence in Innovation

CEDEA/ICGT and INSERM/Univ. Paris-Saclay - France

Author Profile

ORCID

Early academic pursuits 🎓

Jerzy trojan completed his doctorate d’état ès sciences (hdr) at the prestigious sorbonne - p&m curie. during this formative period, he laid the groundwork for his future contributions to biomedical science, specifically in the field of cancerology. his early research endeavors, characterized by a rigorous scientific approach, focused on critical aspects of oncology and laid the foundation for his later groundbreaking work.

Professional endeavors 🏥

Jerzy has held various esteemed positions throughout his career, reflecting his commitment to advancing cancer research. he is currently a visiting professor at the insitm, cancer center, and paris-saclay university in villejuif, france, where he has been since 2019. before this, he served as president and research director at the international cancer gene therapy and oncology diagnostics center (ceadea) in bogota, colombia, and has also held prominent roles in institutions across the usa and europe, including case western reserve university and the sidney kimmel cancer center. these diverse experiences have equipped him with a comprehensive understanding of both the scientific and clinical aspects of cancer treatment.

Contributions and research focus 🔬

Dr. trojan is best known for establishing cancer gene therapy, particularly immuno-gene therapy, as a pivotal domain within oncology. his pioneering research, highlighted in publications from 1993, led to significant advancements in the treatment of glioblastoma, showcasing the therapeutic potential of gene therapy. Immuno - gene therapy additionally, he explored the intersection between neuro-ontogenesis and neuro-oncogenesis, identifying afp and igf-i as novel biomarkers, which have implications for understanding central nervous system differentiation and cancer progression.

Accolades and recognition 🏆

In recognition of his substantial contributions to biomedical science, jerzy was elected as a member of the prestigious french academy of medicine (anm) in paris in 2017. his extensive body of work includes nearly 370 publications, encompassing 140 articles, 102 book chapters, and four books, which have garnered over 3,500 Immuno - gene therapy citations. this impressive scholarly output underscores his impact and influence in the field of cancer research.

Impact and influence 🌍

Dr. trojan's research has significantly shaped the landscape of cancer therapy, particularly in immunotherapy. his establishment of immuno-gene therapy has opened new avenues for treating aggressive cancers, thus influencing both academic research and clinical practices. his work has not only contributed to theoretical Immuno - gene therapy advancements but has also informed practical applications that benefit patients facing challenging diagnoses.

Legacy and future contributions 🔮

With an enduring commitment to advancing cancer research, jerzy trojan continues to influence the field through his current role as a visiting professor and research director. his legacy is evident in the ongoing projects aimed at improving cancer treatment outcomes, particularly through innovative therapeutic strategies. as he continues to publish and mentor the next generation of researchers, his contributions will undoubtedly have a lasting impact on the future of oncology and gene therapy.

Notable Publications 

  • Title: Precancerous Disease Systemic Lupus Erythematosus–The Role of BAFF in Corticosteroids Treatment
    Author: J. Trojan et al.
    Journal: Medical Research and Its Applications, Vol. 6, Pages 114-127
    DOI: 10.9734/bpi/mria/v6/7520C
    Publication Date: June 3, 2024
  • Title: Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
    Author: J. Trojan
    Journal: Current Medicinal Chemistry, Vol. 31, Pages 1982-2002
    DOI: 10.2174/0109298673231106095141
    Publication Date: March 11, 2024
  • Title: Establishment of Cancer Gene Therapy
    Author: J. Trojan
    Journal: Cambridge Scholars Publishing
    Publication Date: March 2, 2023
  • Title: Neoplastic brain, glioblastoma and immunotherapy
    Author: J. Trojan et al.
    Journal: In: Brain and Spinal Tumors - Primary and Secondary, Ed. L.R. Morgan, F.B. Sarica, InTechOpen
    Publication Date: 2020
  • Title: In vitro technical aspects of Anti–Gene IGF-I vaccines against glioma
    Author: J. Trojan et al.
    Journal: IBR, Vol. 3(1), Pages 43-48
    Publication Date: 2019

Prof. Zhiguo Wang – Polypharmacology – Outstanding Scientist Award

Posted on by sciencefather

Prof. Zhiguo Wang - Polypharmacology - Outstanding Scientist Award

Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Bidirectional Complications among Chronic Conditions, Jinan University, China - China 

Author Profile

SCOPUS 

ORCID

GOOGLE SCHOLAR

Early academic pursuits 🎓

Zhiguo Wang embarked on his academic journey with a strong foundation in pharmacology, pursuing his studies at Harbin Medical University in Heilongjiang, China. His early work laid the groundwork for a distinguished career focused on understanding chronic diseases and their complex interrelations. His rigorous training and commitment to research established him as a formidable scholar in the field of cardiovascular and chronic disease research.

Professional endeavors 🏢

Throughout his career, Zhiguo has held numerous prestigious positions, demonstrating his leadership in the medical and research communities. He is currently the Director and Professor at the Guangdong Provincial Key Laboratory for Mechanistic and Translational Research on Chronic Disease Complex Complications at Jinan University in Guangzhou, China. His role as a chief scientist and professor across various departments at the First Affiliated Hospital of Jinan University reflects his multifaceted expertise. Additionally, he has contributed significantly as a Distinguished Professor at Harbin Medical University and held a visiting professorship at the Montreal Heart Institute in Canada.

Contributions and research focus 🔬

Zhiguo's research focuses on the mechanistic and translational aspects of chronic diseases, particularly the bidirectional complications arising from these conditions. He has pioneered studies that explore the pathophysiology of cardiovascular diseases and their links to metabolic disorders. His work employs innovative Polypharmacology methodologies to investigate the underlying mechanisms of disease progression and to develop effective therapeutic strategies, aiming to improve patient outcomes in chronic disease management.

Accolades and recognition 🏅

Zhiguo Wang has received numerous accolades for his contributions to medical research, including being a Fellow of the American Heart Association (FAHA) and a Polypharmacology Fellow of the European Society of Cardiology (FESC). His recognition as a Marion L. Munro Research Scholar by the Canadian Diabetes Association further underscores his impactful research in chronic disease mechanisms. His extensive publication record in high-impact journals reflects his influence and standing in the academic community.

Impact and influence 🌍

Zhiguo's research has made a significant impact on the understanding of chronic diseases and their complications, influencing both clinical practice and public health strategies. His work is instrumental in bridging the gap between basic science and clinical applications, ultimately contributing to improved therapeutic approaches Polypharmacology for patients suffering from chronic conditions. He is a sought-after speaker and mentor, inspiring the next generation of researchers in his field.

Legacy and future contributions 🔮

As a leader in chronic disease research, Zhiguo Wang’s legacy is built on his commitment to advancing scientific knowledge and improving patient care. His ongoing research aims to unravel the complexities of chronic disease interactions and to foster innovative therapeutic strategies. With a focus on translational research, Zhiguo's future contributions are poised to drive significant advancements in understanding and treating chronic conditions, leaving a lasting impact on the field and enhancing healthcare outcomes globally.

Notable Publications 

Topical GDF11 accelerates skin wound healing in both type 1 and 2 diabetic mouse models  2020(9)

Metformin Shortens Prolonged QT Interval in Diabetic Mice by Inhibiting L-Type Calcium Current 2020(8)

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis 2020(38)

Increase of late sodium current contributes to enhanced susceptibility to atrial fibrillation in diabetic mice 2019(22)

Systematic analysis of intestinal microRNAs expression in HCC: Identification of suitable reference genes in fecal samples 2019(4)